Novavax, Inc.
MX ˙ BMV ˙ US6700024010
SecurityMX:NVAX / Novavax, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership11,847 shares
Latest Disclosed Value $ 96,434
Dimensional Fund Advisors Lp reports 6.17% increase in ownership of NVAX / Novavax, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 11,847 shares of Novavax, Inc. (MX:NVAX) valued at $96,434 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 11,158 shares of Novavax, Inc.. This represents a change in shares of 6.17% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F NOVAVAX COM NEW 670002401 11,847 689 6.17 96 29.73 0.0000
2026-02-12 2025-12-31 13F NOVAVAX COM NEW 670002401 11,158 11,158 75 0.0000
2022-11-10 2022-09-30 13F NOVAVAX COM NEW 670002401 0 -10,513 -100.00 0 -100.00
2022-08-12 2022-06-30 13F NOVAVAX COM NEW 670002401 10,513 -52,359 -83.28 541 -88.32 0.0002
2022-05-13 2022-03-31 13F NOVAVAX COM 670002401 62,872 -27,247 -30.23 4,631 -64.11 0.0014
2022-02-09 2021-12-31 13F NOVAVAX COM 670002401 90,119 -180 -0.20 12,903 -31.06 0.0039
2021-11-12 2021-09-30 13F NOVAVAX COM 670002401 90,299 -12,213 -11.91 18,717 -13.99 0.0060
2021-08-12 2021-06-30 13F NOVAVAX COM 670002401 102,512 7,553 7.95 21,761 26.44 0.0069
2021-05-14 2021-03-31 13F NOVAVAX COM 670002401 94,959 -2,231 -2.30 17,211 58.67 0.0057
2021-03-08 2020-12-31 13F/A-2 NOVAVAX COM 670002401 97,190 5,090 5.53 10,847 8.71 0.0039
2021-02-11 2020-12-31 13F NOVAVAX COM 670002401 97,190 5,090 10,847 3,917.3599
2020-11-12 2020-09-30 13F NOVAVAX COM 670002401 92,100 92,100 9,978 0.0042
2016-02-10 2015-12-31 13F NOVAVAX COM 670002104 0 -305,449 -100.00 0 -100.00
2015-11-13 2015-09-30 13F NOVAVAX COM 670002104 305,449 305,449 2,160 0.0014
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.